Patent · US Active

Conjugated factor VIII molecules

US9150848B2 · kind B2 · utility

0Cited by
196References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 8, 2014
Grant dateOct 6, 2015
Priority date
Expiry dateMay 8, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to B-domain truncated Factor VIII molecules with a modified circulatory half life, said molecule being covalently conjugated with a hydrophilic polymer. The invention furthermore relates to methods for obtaining such molecules as well as use of such molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.